| Global prevalence and genotype distribution of hepatitis C virus infection in 2015: a modelling study S Blach, S Zeuzem, M Manns, I Altraif, AS Duberg, DH Muljono, I Waked, ... The lancet Gastroenterology & hepatology 2 (3), 161-176, 2017 | 2076 | 2017 |
| Development of the quinolones MI Andersson, AP MacGowan Journal of Antimicrobial Chemotherapy 51 (suppl_1), 1-11, 2003 | 755 | 2003 |
| Gonorrhoea treatment failure caused by a Neisseria gonorrhoeae strain with combined ceftriaxone and high-level azithromycin resistance, England, February 2018 DW Eyre, ND Sanderson, E Lord, N Regisford-Reimmer, K Chau, ... Eurosurveillance 23 (27), 1800323, 2018 | 329 | 2018 |
| Performance characteristics of five immunoassays for SARS-CoV-2: a head-to-head benchmark comparison M Ainsworth, M Andersson, K Auckland, JK Baillie, E Barnes, S Beer, ... The Lancet Infectious Diseases 20 (12), 1390-1400, 2020 | 316 | 2020 |
| Global change in hepatitis C virus prevalence and cascade of care between 2015 and 2020: a modelling study S Blach, NA Terrault, F Tacke, I Gamkrelidze, A Craxi, J Tanaka, I Waked, ... The Lancet Gastroenterology & Hepatology 7 (5), 396-415, 2022 | 309 | 2022 |
| SARS-CoV-2 within-host diversity and transmission KA Lythgoe, M Hall, L Ferretti, M de Cesare, G MacIntyre-Cockett, ... Science 372 (6539), eabg0821, 2021 | 300 | 2021 |
| Inhaled budesonide for COVID-19 in people at high risk of complications in the community in the UK (PRINCIPLE): a randomised, controlled, open-label, adaptive platform trial LM Yu, M Bafadhel, J Dorward, G Hayward, BR Saville, O Gbinigie, ... The Lancet 398 (10303), 843-855, 2021 | 284 | 2021 |
| Differential occupational risks to healthcare workers from SARS-CoV-2 observed during a prospective observational study DW Eyre, SF Lumley, D O'Donnell, M Campbell, E Sims, E Lawson, ... elife 9, e60675, 2020 | 271 | 2020 |
| Molnupiravir plus usual care versus usual care alone as early treatment for adults with COVID-19 at increased risk of adverse outcomes (PANORAMIC): an open-label, platform … CC Butler, FDR Hobbs, OA Gbinigie, NM Rahman, G Hayward, ... The Lancet 401 (10373), 281-293, 2023 | 270 | 2023 |
| The present and future disease burden of hepatitis C virus (HCV) infections with today's treatment paradigm–volume 2 A Hatzakis, V Chulanov, AC Gadano, C Bergin, Z Ben‐Ari, J Mossong, ... Journal of viral hepatitis 22, 26-45, 2015 | 247* | 2015 |
| Antibody testing for COVID-19: A report from the National COVID Scientific Advisory Panel ER Adams, M Ainsworth, R Anand, MI Andersson, K Auckland, JK Baillie, ... Wellcome Open Research 5, 2020 | 221 | 2020 |
| SARS-CoV-2 RNA detected in blood products from patients with COVID-19 is not associated with infectious virus MI Andersson, CV Arancibia-Carcamo, K Auckland, JK Baillie, E Barnes, ... Wellcome open research 5, 2020 | 171 | 2020 |
| The duration, dynamics, and determinants of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) antibody responses in individual healthcare workers SF Lumley, J Wei, D O’Donnell, NE Stoesser, PC Matthews, A Howarth, ... Clinical Infectious Diseases 73 (3), e699-e709, 2021 | 159 | 2021 |
| Trends over time in Escherichia coli bloodstream infections, urinary tract infections, and antibiotic susceptibilities in Oxfordshire, UK, 1998–2016: a study of electronic … KD Vihta, N Stoesser, MJ Llewelyn, TP Quan, T Davies, NJ Fawcett, ... The Lancet Infectious Diseases 18 (10), 1138-1149, 2018 | 150 | 2018 |
| Metagenomic nanopore sequencing of influenza virus direct from clinical respiratory samples K Lewandowski, Y Xu, ST Pullan, SF Lumley, D Foster, N Sanderson, ... Journal of clinical microbiology 58 (1), 10.1128/jcm. 00963-19, 2019 | 146 | 2019 |
| Historical epidemiology of hepatitis C virus (HCV) in select countries–volume 2 V Saraswat, S Norris, RJ De Knegt, JF Sanchez Avila, M Sonderup, ... Journal of viral hepatitis 22, 6-25, 2015 | 142 | 2015 |
| Hepatitis B virus infection as a neglected tropical disease GA O’Hara, AL McNaughton, T Maponga, P Jooste, P Ocama, R Chilengi, ... PLoS neglected tropical diseases 11 (10), e0005842, 2017 | 105 | 2017 |
| Evaluation of antibody testing for SARS-Cov-2 using ELISA and lateral flow immunoassays E Adams, M Ainsworth, R Anand, MI Andersson, K Auckland, JK Baillie, ... MedRxiv, 2020 | 101 | 2020 |
| Genetic relatedness of ceftriaxone-resistant and high-level azithromycin resistant Neisseria gonorrhoeae cases, United Kingdom and Australia, February to April 2018 AV Jennison, D Whiley, MM Lahra, RM Graham, MJ Cole, G Hughes, ... Eurosurveillance 24 (8), 1900118, 2019 | 98 | 2019 |
| Strategies to manage hepatitis C virus (HCV) infection disease burden–volume 2 E Gane, D Kershenobich, C Seguin‐Devaux, P Kristian, I Aho, O Dalgard, ... Journal of viral hepatitis 22, 46-73, 2015 | 91 | 2015 |
